SEC Gives Largest Whistleblower Award in History
The SEC will award a record-breaking $48 million to a single whistleblower. This is excellent news for consumers and investors. The SEC is taking fraud extremely seriously. Also, the agency is rewarding good-doers for coming forward. The Law Protects and Rewards a Whistleblower When a knowledgeable attorney like those found at The Michael Brady Lynch
Read More
Dangers of Cruise Excursions
For many, cruise ship accidents don’t just occur on the actual ship. In fact, many injuries happen after passengers leave the cruise ship. Passengers have the option to book shore excursion activities. These range from snorkeling, parasailing, hiking and more. The activities may be different, but all passengers have the same false idea that these
Read More
Michael Lynch to Give Pradaxa Update at Mass Tort Nexus Conference
In Fort Lauderdale, FL, on March 11, Attorney Michel Brady Lynch, Esq. of The Michael Brady Lynch Firm in Winter Park will inform attorneys from around the country on the newest developments in the Pradaxa litigation. Attorney Michael Brady Lynch’s lecture is part of an intense 4-Day Immersion Course sponsored by Mass Tort Nexus. During
Read More
Building Inspectors Involved in Asbestos Fraud
When a business pays off an inspector to say their building does not have asbestos when it does, it is a serious crime. In fact, it could mean life or death. Asbestos is a deadly substance that can cause mesothelioma or cancer. About Asbestos The Environmental Protection Agency (EPA) identifies six types of asbestos minerals:
Read More
Aspirin As Effective As Xarelto For Post-Surgical Bleeds
Researchers studying the effects of Xarelto and aspirin use post surgery found no notable difference in post-surgical bleeds between the two. In fact, the only difference between Xarelto and aspirin is cost. Consumers pay around $425 a month for Xarelto compared to a dollar for aspirin. About Xarelto Anticoagulants, commonly known as blood-thinners, work by
Read More
Tasigna Linked to Coronary Artery Disease
Researchers have linked the popular cancer treatment drug, Tasigna (generic name, nilotinib), manufactured by Novartis to irreversible atherosclerosis, coronary artery disease, and peripheral arterial disease (PAD), which can be deadly. This condition causes plaque build-up in a patient’s artery walls, causing them to harden and become thick and narrow. Thus, it lessens the ability for blood
Read MoreBank of America Pays $3.4M to Whistleblower
In the newest Bank of America whistleblower settlement, the financial giant agreed to pay $3.4 million dollars to a courageous whistleblower. This comes after claims that the bank still was not meeting documentation standards for foreclosures. This is even after agreeing to as part of a $25 billion consent judgment involving the bank. The Law Protects
Read More
Asbestos Injuries Bring Large Settlement to Factory Workers
A Wisconsin court ordered the corporate owner of a closed factory to pay more than $500,000 in fines and medical expenses after exposing workers to deadly asbestos. The factory violated the Clean Air Act and admitted to not giving workers the proper asbestos safety equipment. About Asbestos Asbestos once filled countless U.S. homes and businesses
Read More
Synvisc-One Bacteria Contaminate Revealed
Last December, Sanofi Genzyme recalled 12,380 Synvisc-One syringes from lot number 7RSL021 sold nationwide in 36 states from October 25, 2017, through November 7, 2017, due to microbial contamination. Now, through a Class 2 recall, the company has revealed the Synvisc-One bacterium that has caused thousands of people to experience pain so intense that they are
Read More
Researchers Link Cancer Drug Tasigna to Atherosclerosis
Researchers continue to link the popular cancer treatment drug, Tasigna to atherosclerosis. However, the manufacturer of the drug, Novartis still continues to deny the connection. In fact, they won’t update the label to warn American consumers even though they warned Canadian ones. About Tasigna Manufacturer Novartis received FDA approval for Tasigna in 2007. Tasigna
Read More